Combined Ingestion of Tea Catechin and Citrus β-Cryptoxanthin Improves Liver Function via Adipokines in Chronic Obesity.

activin E adipokines catechin flavonoid green tea high-calorie obesity polyphenol β-carotene β-cryptoxanthin

Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
27 Jul 2023
Historique:
received: 09 06 2023
revised: 12 07 2023
accepted: 25 07 2023
medline: 14 8 2023
pubmed: 12 8 2023
entrez: 12 8 2023
Statut: epublish

Résumé

Recently, there has been an increase in the number of obese individuals, which has elevated the risk of related diseases. Although several studies have been performed to develop a definitive treatment for obesity, no solution has yet been achieved. Recent evidence suggests that tea catechins possess antiobesity effects; however, an impractical amount of catechin may be required to achieve antiobesity effects in humans. Moreover, studies are yet to elucidate the effects of the combined treatment of tea catechins with other substances. Here, we investigated the synergistic effects of catechins and β-cryptoxanthin in high-calorie diet-induced mice. Combined treatment with catechins and β-cryptoxanthin significantly suppressed obesity-induced weight gain and adipocyte size and area, restoring serum parameters to normal. Additionally, combined treatment with catechins and β-cryptoxanthin suppressed inflammatory responses in adipocytes, restored adiponectin levels to normal, protected the liver against obesity-induced damage, and restored normal liver function. Moreover, activin E level was restored to normal, possibly affecting the energy metabolism of brown adipocytes. Overall, these results suggest that the combined ingestion of tea catechins and β-cryptoxanthin was not only effective against obesity but may also help to prevent obesity-related diseases, such as diabetes and cardiovascular diseases.

Identifiants

pubmed: 37571282
pii: nu15153345
doi: 10.3390/nu15153345
pmc: PMC10421220
pii:
doi:

Substances chimiques

Adipokines 0
Beta-Cryptoxanthin 0
Catechin 8R1V1STN48
Tea 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 23K08620

Références

J Nutr. 2005 Feb;135(2):155-9
pubmed: 15671206
Polymers (Basel). 2020 Jun 22;12(6):
pubmed: 32580366
Nat Rev Immunol. 2008 Dec;8(12):958-69
pubmed: 19029990
Int J Mol Sci. 2023 Apr 11;24(8):
pubmed: 37108217
Appl Biochem Biotechnol. 2022 Aug;194(8):3594-3608
pubmed: 35460454
Turk J Pharm Sci. 2022 Jun 27;19(3):246-250
pubmed: 35773997
Ultrastruct Pathol. 2015 Feb;39(1):30-7
pubmed: 25192055
Molecules. 2022 May 19;27(10):
pubmed: 35630735
JAMA Netw Open. 2022 Sep 1;5(9):e2233760
pubmed: 36169954
Curr Pharm Des. 2017 Sep 26;:
pubmed: 28950824
Int J Mol Sci. 2022 Feb 11;23(4):
pubmed: 35216129
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018 Jun;162(2):79-82
pubmed: 29765169
Aging (Albany NY). 2022 Mar 28;14(6):2695-2719
pubmed: 35347086
Inflamm Res. 2021 Mar;70(3):343-358
pubmed: 33564933
Nat Med. 2007 Mar;13(3):332-9
pubmed: 17268472
Tidsskr Nor Laegeforen. 2022 Oct 04;142(14):
pubmed: 36226431
Yakugaku Zasshi. 2014;134(7):829-38
pubmed: 24989474
Neurochem Res. 2020 Oct;45(10):2487-2498
pubmed: 32789797
Springerplus. 2016 Aug 18;5(1):1363
pubmed: 27588256
J Agric Food Chem. 2003 Dec 3;51(25):7303-7
pubmed: 14640575
Nutrients. 2021 May 21;13(6):
pubmed: 34063868
J Clin Med. 2022 Mar 17;11(6):
pubmed: 35330003
Appl Physiol Nutr Metab. 2019 Jun;44(6):587-594
pubmed: 30345803
Obes Res Clin Pract. 2022 May-Jun;16(3):197-205
pubmed: 35659463
Int J Obes Relat Metab Disord. 2002 Nov;26(11):1459-64
pubmed: 12439647
Nat Commun. 2018 Nov 19;9(1):4863
pubmed: 30451856
Can J Physiol Pharmacol. 2021 Jun;99(6):599-608
pubmed: 33064960
J Clin Med. 2022 Jun 09;11(12):
pubmed: 35743382
Lasers Surg Med. 2015 Oct;47(8):634-42
pubmed: 26220050
Brain Res. 1982 Mar 25;236(2):497-504
pubmed: 7039767
Nature. 2003 Jun 12;423(6941):762-9
pubmed: 12802337
Int J Obes (Lond). 2017 Nov;41(11):1676-1684
pubmed: 28761130
Biomed Res Int. 2016;2016:5251738
pubmed: 27437400
Am J Clin Nutr. 2017 Apr;105(4):873-881
pubmed: 28275131
Biochim Biophys Acta. 1992 Jul 29;1127(2):141-6
pubmed: 1643098
Yakugaku Zasshi. 2016;136(7):1031-40
pubmed: 27374966
Med Sci Monit. 2013 Nov 27;19:1063-72
pubmed: 24280776
Science. 1969 May 9;164(3880):719-21
pubmed: 5778021
Cells. 2022 Dec 10;11(24):
pubmed: 36552762
J Biol Chem. 2003 Jan 24;278(4):2461-8
pubmed: 12431986
Nat Rev Immunol. 2011 Oct 14;11(11):723-37
pubmed: 21997792
Int J Mol Sci. 2019 Jun 12;20(12):
pubmed: 31212761
Obesity (Silver Spring). 2009 Feb;17(2):310-7
pubmed: 19008868
Cell Rep. 2018 Oct 30;25(5):1193-1203
pubmed: 30380411
Evid Based Complement Alternat Med. 2022 Apr 11;2022:7576132
pubmed: 35449814
Evid Based Nurs. 2015 Jan;18(1):29-30
pubmed: 24842056
Front Endocrinol (Lausanne). 2022 May 26;13:859245
pubmed: 35721754
J Nutr. 2009 Feb;139(2):264-70
pubmed: 19074207
Int J Mol Sci. 2022 Feb 19;23(4):
pubmed: 35216423
Endocr Rev. 2018 Jun 1;39(3):261-273
pubmed: 29490014
Sci Rep. 2021 Sep 24;11(1):19067
pubmed: 34561541
Mol Nutr Food Res. 2016 Nov;60(11):2467-2480
pubmed: 27393711

Auteurs

Kazuhiko Nakadate (K)

Department of Basic Science, Educational and Research Center for Pharmacy, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose 204-8588, Tokyo, Japan.

Kiyoharu Kawakami (K)

Department of Basic Science, Educational and Research Center for Pharmacy, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose 204-8588, Tokyo, Japan.

Noriko Yamazaki (N)

Department of Community Health Care and Sciences, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose 204-8588, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH